Department of Cerebral Surgery, The First People's Hospital of Jiande, Jiande, China.
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5597-5604. doi: 10.26355/eurrev_201809_15824.
This study was conducted to analyze the effect of miR-7 on the inflammatory response of microglia in vitro and in vivo by constructing an intracerebral hemorrhage model.
In this study, we first established a model of cerebral hemorrhage in rat for in vivo experiments, and used lipoprotein (LPS) to induce an inflammatory response development in microglial cells, and constructed microglial inflammation models for in vitro experiments. Quantitative Real-time-polymerase chain reaction (qRT-PCR) was used to detect the expression of miR-7 in the rat model of cerebral hemorrhage and microglia with inflammation. The effect of miR-7 on the inflammation caused by intracerebral hemorrhage was evaluated through measuring the expression of IL-1β, IL-8 and TNF-α by enzyme-linked immunosorbent assay (ELISA). Dual luciferase reporter assay was used to detect the binding site of miR-7 to TLR4. Western blot was used to evaluate the level of TLR4 after overexpression and knockdown of miR-7 and to evaluate whether miR-7 alleviated the secondary inflammatory response of microglia after cerebral hemorrhage by inhibiting the expression of TLR4.
The expression of miR-7 in the rat cerebral hemorrhage model and microglial inflammation model tissue was significantly lower than that in the normal control group. Expression of inflammatory cytokines including IL-1β, IL-8 and TNF-α was significantly increased in rats with intracerebral hemorrhage and microglial inflammation in rats, and the expression of these inflammatory cytokines was partially reversed after overexpression of miR-7. Double luciferase reporter gene and ELISA results showed that miR-7 could inhibit the expression of TLR4 and relieve the secondary inflammatory response of microglia after cerebral hemorrhage.
We demonstrated that, in in vivo and in vitro experiments, miR-7 could reduce the LPS-induced inflammatory response produced by microglial cells, and alleviate the inflammation in the brain of rats with cerebral hemorrhage.
本研究通过构建脑出血模型,分析 miR-7 对体外和体内小胶质细胞炎症反应的影响。
本研究首先建立大鼠脑出血模型进行体内实验,采用脂蛋白(LPS)诱导小胶质细胞炎症反应,构建小胶质细胞炎症模型进行体外实验。采用实时定量聚合酶链反应(qRT-PCR)检测大鼠脑出血模型和炎症小胶质细胞中 miR-7 的表达。通过酶联免疫吸附试验(ELISA)检测 miR-7 对脑出血引起的炎症的影响,测量白细胞介素 1β(IL-1β)、白细胞介素 8(IL-8)和肿瘤坏死因子-α(TNF-α)的表达。双荧光素酶报告基因检测 miR-7 与 TLR4 的结合位点。Western blot 用于评估 miR-7 过表达和敲低后 TLR4 的水平,并通过抑制 TLR4 的表达来评估 miR-7 是否减轻脑出血后小胶质细胞的继发性炎症反应。
大鼠脑出血模型和小胶质细胞炎症模型组织中 miR-7 的表达明显低于正常对照组。脑出血大鼠和小胶质细胞炎症大鼠组织中包括 IL-1β、IL-8 和 TNF-α 在内的炎症细胞因子的表达明显增加,过表达 miR-7 后这些炎症细胞因子的表达部分逆转。双荧光素酶报告基因和 ELISA 结果表明,miR-7 可以抑制 TLR4 的表达,减轻脑出血后小胶质细胞的继发性炎症反应。
在体内和体外实验中,我们证明 miR-7 可以降低 LPS 诱导的小胶质细胞炎症反应,并减轻脑出血大鼠大脑中的炎症。